Schiffrin EL - Search Results

1

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk.

Padwal RS, Hemmelgarn BR, Khan NA, Grover S, McKay DW, Wilson T, Penner B, Burgess E, McAlister FA, Bolli P, Hill MD, Mahon J, Myers MG, Abbott C, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Cloutier L, Chockalingam A, Rabkin SW, Dawes M, Touyz RM, Bell C, Burns KD, Ruzicka M, Campbell NR, Vallée M, Prasad R, Lebel M, Tobe SW; Canadian Hypertension Education Program. Padwal RS, et al. Among authors: schiffrin el. Can J Cardiol. 2009 May;25(5):279-86. doi: 10.1016/s0828-282x(09)70491-x. Can J Cardiol. 2009. PMID: 19417858 Free PMC article. Review.

2

Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats.

Park JB, Touyz RM, Chen X, Schiffrin EL. Park JB, et al. Among authors: schiffrin el. Am J Hypertens. 2002 Jan;15(1 Pt 1):78-84. doi: 10.1016/s0895-7061(01)02233-6. Am J Hypertens. 2002. PMID: 11824865

3

Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.

Touyz RM, Wu XH, He G, Salomon S, Schiffrin EL. Touyz RM, et al. Among authors: schiffrin el. Hypertension. 2002 Feb;39(2 Pt 2):479-85. doi: 10.1161/hy02t2.102909. Hypertension. 2002. PMID: 11882594

4

Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.

Pu Q, Touyz RM, Schiffrin EL. Pu Q, et al. Among authors: schiffrin el. J Hypertens. 2002 May;20(5):899-907. doi: 10.1097/00004872-200205000-00025. J Hypertens. 2002. PMID: 12011651

5

Endothelin A receptor blockade decreases expression of growth factors and collagen and improves matrix metalloproteinase-2 activity in kidneys from stroke-prone spontaneously hypertensive rats.

Tostes RC, Touyz RM, He G, Ammarguellat F, Schiffrin EL. Tostes RC, et al. Among authors: schiffrin el. J Cardiovasc Pharmacol. 2002 Jun;39(6):892-900. doi: 10.1097/00005344-200206000-00015. J Cardiovasc Pharmacol. 2002. PMID: 12021584

6

Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats.

Touyz RM, Deschepper C, Park JB, He G, Chen X, Neves MF, Virdis A, Schiffrin EL. Touyz RM, et al. Among authors: schiffrin el. J Hypertens. 2002 Jun;20(6):1127-34. doi: 10.1097/00004872-200206000-00024. J Hypertens. 2002. PMID: 12023682

7

Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.

Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL. Touyz RM, et al. Among authors: schiffrin el. Circ Res. 2002 Jun 14;90(11):1205-13. doi: 10.1161/01.res.0000020404.01971.2f. Circ Res. 2002. PMID: 12065324

8

Tyrosine kinase inhibition attenuates vasopressin-induced contraction of mesenteric resistance arteries: alterations in spontaneously hypertensive rats.

Endemann D, Touyz RM, Yao G, Schiffrin EL. Endemann D, et al. Among authors: schiffrin el. J Cardiovasc Pharmacol. 2002 Jul;40(1):123-32. doi: 10.1097/00005344-200207000-00015. J Cardiovasc Pharmacol. 2002. PMID: 12072585

9

The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.

Zarnke KB, McAlister FA, Campbell NR, Levine M, Schiffrin EL, Grover S, McKay DW, Myers MG, Wilson TW, Rabkin SW, Feldman RD, Burgess E, Bolli P, Honos G, Lebel M, Mann K, Abbott C, Tobe S, Petrella R, Touyz RM; Canadian Hypertension Recommendations Working Group. Zarnke KB, et al. Among authors: schiffrin el. Can J Cardiol. 2002 Jun;18(6):604-24. Can J Cardiol. 2002. PMID: 12107419

10

The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.

McAlister FA, Zarnke KB, Campbell NR, Feldman RD, Levine M, Mahon J, Grover SA, Lewanczuk R, Leenen F, Tobe S, Lebel M, Stone J, Schiffrin EL, Rabkin SW, Ogilvie RI, Larochelle P, Jones C, Honos G, Fodor G, Burgess E, Hamet P, Herman R, Irvine J, Culleton B, Wright JM; Canadian Hypertension Recommendations Working Group. McAlister FA, et al. Among authors: schiffrin el. Can J Cardiol. 2002 Jun;18(6):625-41. Can J Cardiol. 2002. PMID: 12107420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters